EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gut microbial community structure, metabolic signature, and resistome in dyslipidemia: implications for cardiovascular disease management

Soomin Lee, Hyung-Lae Kim, Shahbaz Raza, Eun-Ju Lee, Yoosoo Chang, Seungho Ryu iD, Juhee Cho, Han-Na Kim iD

Microbiology Spectrum · 07.04.2026 · 14 (4)

DOI: 10.1128/spectrum.00971-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 07.04.2026. Verfasst von Soomin Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Research Design and Evaluation, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, , Seou…. Hauptthemen laut MEDLINE: Dyslipidemias, Cardiovascular Diseases, Gastrointestinal Microbiome, Bacteria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dyslipidemia, characterized by abnormal blood lipid levels, constitutes a significant risk factor for cardiovascular disease. Emerging evidence indicates that the gut microbiota influences lipid metabolism, although findings across studies have been inconsistent. In this cross-sectional investigation, we analyzed the composition of gut microbiota, associated metabolic pathways, predicted gut metabolites, and the resistome in 1,384 participants (including 895 individuals with dyslipidemia and 489 controls) through shotgun metagenomic sequencing. Our findings demonstrated that Bacteroides caccae was enriched among dyslipidemia cases, potentially contributing to inflammation and altered lipid metabolism. Conversely, Coprococcus eutactus and Coprococcus catus , recognized producers of short-chain fatty acids (SCFAs) involved in lipid regulation, as well as Blautia obeum , known to be positively affected by SCFAs, were more prevalent in the control group. Additionally, we identified an enrichment of the gene family responsible for dTDP-beta-D-fucofuranose biosynthesis, associated with bacterial pathogenicity, in dyslipidemia cases, with Bacteroides stercoris serving as a major contributor. Dyslipidemia cases also exhibited depletion of glycogen and peptidoglycan biosynthesis pathways, which may compromise energy storage and immune function, alongside decreased levels of pseudouridine, a molecule involved in RNA metabolism. Furthermore, a marginal increase in abundance of antibiotic-resistance genes, tetQ , was observed in dyslipidemia cases, suggesting a potential link between the gut resistome and metabolic dysregulation. These results offer novel insights into the role of gut microbiota in the pathophysiology of dyslipidemia and underscore potential microbiome-targeted interventions for metabolic disease management. IMPORTANCE Dyslipidemia, characterized by abnormal blood lipid levels, is a significant risk factor for cardiovascular disease. Emerging evidence suggests that the gut microbiota plays a role in lipid metabolism, although findings across studies have varied. This study analyzed the gut microbiota, metabolic pathways, predicted gut metabolites, and antimicrobial resistance genes in 1,384 participants using shotgun metagenomic sequencing. Individuals with dyslipidemia exhibited an imbalance in gut bacteria, including an increase in Bacteroides caccae , a species associated with inflammation, and a decrease in short-chain fatty acid-producing bacteria such as Coprococcus eutactus and Blautia obeum , which support metabolic health. Furthermore, we identified significant changes in microbial metabolic pathways related to energy storage and immune function, as well as an increased abundance of tetracycline resistance genes ( tetQ ), suggesting a potential link between dyslipidemia and antimicrobial resistance. Our study provides a comprehensive overview of dyslipidemia-associated gut microbial alterations, highlighting potential mechanistic links and therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DyslipidemiasCardiovascular DiseasesGastrointestinal MicrobiomeBacteriaHumansLipid MetabolismCross-Sectional StudiesFemaleMetagenomicsMaleMiddle Aged

Stichwörter der Autor:innen

cardiovascular diseasedyslipidemiafunctional profilinggut microbiomeshotgun metagenomics

Autor:innen und Institutionen

  • Department of Clinical Research Design and Evaluation, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, , Seoul, Republic of Korea.
  • Department of Biochemistry, College of Medicine, Ewha Womans University, Seoul, Republic of Korea.
  • Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Department of Occupational and Environmental Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Center for Clinical Epidemiology, Samsung Medical Center, Sungkyunkwan University, , Seoul, Republic of Korea.
  • Departments of Epidemiology and Medicine, and Welch Center for Prevention, Epidemiology and Clinical Research, John Hopkins Medical Institutions, Baltimore, Maryland, USA.

ORCID-Profile: Seungho Ryu, Han-Na Kim

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Lee, S., Kim, H. L., Raza, S., Lee, E. J., Chang, Y., Ryu, S., Cho, J., & Kim, H. N. (2026). Gut microbial community structure, metabolic signature, and resistome in dyslipidemia: implications for cardiovascular disease management. Microbiology Spectrum, 14(4). https://doi.org/10.1128/spectrum.00971-25

Vancouver

Lee S, Kim HL, Raza S, Lee EJ, Chang Y, Ryu S, et al. Gut microbial community structure, metabolic signature, and resistome in dyslipidemia: implications for cardiovascular disease management. Microbiology Spectrum. 2026;14(4). doi:10.1128/spectrum.00971-25

BibTeX
@article{Lee2026,
  author = {Lee, Soomin and Kim, Hyung-Lae and Raza, Shahbaz and Lee, Eun-Ju and Chang, Yoosoo and Ryu, Seungho and Cho, Juhee and Kim, Han-Na},
  title = {Gut microbial community structure, metabolic signature, and resistome in dyslipidemia: implications for cardiovascular disease management},
  journal = {Microbiology Spectrum},
  year = {2026},
  volume = {14},
  number = {4},
  doi = {10.1128/spectrum.00971-25}
}
Kostenlos starten →